KOL Engagement Dynamics-Influence Levels by Phase
In part 1 of 3 on Navigating KOL Engagement Dynamics-Influence Levels by Phase, we present our first key insight from our KOL engagement strategy report. This article addresses how pharmaceutical companies engage with KOLs possessing specific backgrounds suited to support the activities of the pharmaceutical organization during particular times within a product development lifecycle. The [...]